Uber appoints new UK chief as renewal of London licence looms
Melinda Roylett joins the firm having previously headed the European operation of digital payment firm Square
Company
PRIVATE:[TICKER]
Paracrine is a clinical (late-stage) biopharmaceutical company developing an autologous cell therapy platform targeting some of the greatest unmet needs in healthcare. Our unique multi-dimensional biologic therapy is a "game changer" for complex diseases and conditions.
223 stories · page 12 of 12
Melinda Roylett joins the firm having previously headed the European operation of digital payment firm Square
The NYSE-listed firm reported a net loss of $5.2 billion, up from a deficit of $878 million a year earlier, reflecting $3.9 billion of stock-based compensation expenses related to its IPO earlier this year,
Lenders are anxious about the retail industry, given dwindling mall traffic and the surprise bankruptcy filing of Toys ‘R’ Us last month